<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bronchopulmonary sequestration: Prenatal diagnosis and management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bronchopulmonary sequestration: Prenatal diagnosis and management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Bronchopulmonary sequestration: Prenatal diagnosis and management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Dorothy I Bulas, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alexia Egloff, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Louise Wilkins-Haug, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H31928889"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Congenital lung masses include bronchopulmonary sequestration (BPS, also called lung or pulmonary sequestration), congenital pulmonary airway malformation (CPAM), congenital lobar overinflation, bronchogenic cyst, and bronchial atresia. Hybrid lesions are common, which suggests that these masses represent a spectrum of abnormalities. BPS lies along a spectrum of abnormalities that can affect the normal development of the airways, lung parenchyma, and vasculature. Obstruction is thought to be the underlying etiology, and the level, degree, and timing of the obstruction determines the resulting pathology  (<a class="graphic graphic_figure graphicRef130725" href="/d/graphic/130725.html" rel="external">figure 1</a>) [<a href="#rid1">1-3</a>]. </p><p>The majority of BPS cases are diagnosed in the second trimester, continue to enlarge during the second trimester, and then stabilize or partially regress during the third trimester. Thus, many cases can be managed expectantly; however, a subset of fetuses develop hydrops or massive pleural effusions with mediastinal shift, which usually requires intervention [<a href="#rid4">4</a>]. </p><p>In the absence of other significant congenital anomalies, the postnatal short-term and long-term prognosis of BPS is usually very good, although surgical excision is sometimes performed to relieve respiratory symptoms or prevent future complication (eg, pulmonary infection; rarely heart failure, bleeding, or torsion). Surgery is generally performed in the first year of life and is curative.</p><p>This topic will focus on prenatal diagnosis and management of BPS and hybrid BPS/CPAM lesions. Prenatal diagnosis and management of CPAM alone is reviewed separately. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management"</a>.) Postnatal management and outcome of BPS and CPAM are also reviewed separately. (See  <a class="medical medical_review" href="/d/html/6341.html" rel="external">"Bronchopulmonary sequestration"</a> and  <a class="medical medical_review" href="/d/html/6346.html" rel="external">"Congenital pulmonary airway malformation"</a>.)</p><p class="headingAnchor" id="H1818532569"><span class="h1">ANATOMIC AND EPIDEMIOLOGIC FEATURES OF BPS</span><span class="headingEndMark"> — </span>Bronchopulmonary sequestration (BPS) accounts for a small proportion, 0.15 to 6.4 percent, of congenital lung malformations [<a href="#rid5">5</a>]. The lesion consists of a nonfunctioning mass of lung tissue that lacks normal communication with the tracheobronchial tree and receives its blood supply from the systemic (rather than the pulmonary) circulation [<a href="#rid6">6</a>]. The feeding vessel most commonly originates from the thoracic aorta, although origins from the abdominal aorta or divisions of the abdominal aorta (eg, splenic, celiac, or gastric artery) have been described [<a href="#rid7">7</a>]. Eighty percent of cases occur on the left [<a href="#rid8">8</a>]. </p><p>BPS is classified anatomically as intralobar (ILS) or extralobar (ELS). ILS and ELS are histologically similar but occur in different locations and often have different venous drainage.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>ILS</strong> – In ILS (also known as intrapulmonary sequestration), the mass is located within the normal lung and is covered by the visceral pleura of the lung. ILS accounts for approximately 75 percent of BPS and is almost always located in the lower lobes, most commonly in the left medial or posterior segment [<a href="#rid9">9,10</a>]. Because ILS is connected to normal lung, abnormal connections between it and either the bronchi or the gastrointestinal tract can develop, which increases the risk of postnatal respiratory infections [<a href="#rid11">11</a>]. </p><p></p><p class="bulletIndent1">Most ILS drains via the pulmonary vein to the left atrium, although connections to the vena cava, azygous vein, or right atrium also occur. </p><p></p><p class="bulletIndent1">ILS is distributed equally between the sexes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ELS</strong> – In ELS (also known as extrapulmonary sequestration), the mass is located outside of the normal lung and has its own visceral pleura. Postnatally, approximately 25 percent of BPS is extralobar [<a href="#rid12">12</a>]. An extralobar lesion can occur between the neck and diaphragm, within the diaphragm, or infradiaphragmatically, where it can mimic a suprarenal neuroblastoma [<a href="#rid9">9,12,13</a>]. The most common location is between the left lower lobe and hemidiaphragm (80 percent) [<a href="#rid10">10,14</a>]. Ten to 15 percent are subdiaphragmatic (usually in the suprarenal space) and 90 percent are left-sided [<a href="#rid15">15</a>]. One case report described ELS with combined gastric and intradiaphragmatic locations [<a href="#rid16">16</a>]. Because ELS is not connected to normal lung, both abnormal intrapulmonary connections and postnatal infectious complications are uncommon.</p><p></p><p class="bulletIndent1">Most ELS drains into the systemic circulation through the azygous or hemiazygous vein or vena cava, but sometimes directly into the right atrium [<a href="#rid5">5,11</a>]. Because of the systemic arterial supply and venous drainage, large ELS may develop severe left to right shunts, leading to high-output heart failure [<a href="#rid11">11</a>]. </p><p></p><p class="bulletIndent1">ELS is more likely to affect males and to be associated with anomalies, including congenital diaphragmatic hernia or eventration, heart defects, and foregut anomalies. </p><p></p><p>Hybrid combinations of BPS and congenital pulmonary airway malformation (CPAM) are relatively common, have connections with both the pulmonary and systemic arterial supply, and can have the appearance of a CPAM with multiple cysts.</p><p class="headingAnchor" id="H31929161"><span class="h1">PRENATAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Ultrasound is the primary modality for imaging the fetal chest and detecting fetal chest masses [<a href="#rid17">17</a>], but can have low specificity [<a href="#rid18">18</a>]. Magnetic resonance imaging (MRI) can be a useful adjunct for confirming the presence of a mass, further characterizing normal and abnormal anatomy, and assessing residual lung volume. MRI of lung parenchyma is less limited by maternal obesity, oligohydramnios, overlying ribs, and fetal lie than ultrasound. (See <a class="local">'Role of magnetic resonance imaging'</a> below.)</p><p>The normal fetal lung is shown in the following ultrasound image  (<a class="graphic graphic_diagnosticimage graphicRef63320" href="/d/graphic/63320.html" rel="external">image 1</a>) and MRI  (<a class="graphic graphic_diagnosticimage graphicRef74495" href="/d/graphic/74495.html" rel="external">image 2</a>); imaging the normal fetal lung is reviewed separately. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management", section on 'Appearance of normal lung'</a>.) </p><p class="headingAnchor" id="H31928901"><span class="h2">Ultrasound findings</span></p><p class="headingAnchor" id="H2731879492"><span class="h3">Diagnostic findings</span><span class="headingEndMark"> — </span>Prenatal diagnosis of bronchopulmonary sequestration (BPS) should be suspected upon visualization of a solid appearing, triangular, echogenic chest mass, which is often located in the lower hemithorax adjacent to the diaphragm. Hybrid lesions (BPS and congenital pulmonary airway malformation [CPAM]) have solid and cystic components. The mass is usually unilateral, but bilateral cases have been described [<a href="#rid19">19</a>]. The diagnosis is confirmed by identification of a systemic artery to the mass: usually the thoracic aorta; sometimes the abdominal aorta or one of its divisions  (<a class="graphic graphic_diagnosticimage graphicRef105398" href="/d/graphic/105398.html" rel="external">image 3</a> and <a class="graphic graphic_diagnosticimage graphicRef51114" href="/d/graphic/51114.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef50003" href="/d/graphic/50003.html" rel="external">image 5</a>). </p><p>Color and power Doppler assessments are critical for imaging the systemic vascular supply  (<a class="graphic graphic_diagnosticimage graphicRef51114" href="/d/graphic/51114.html" rel="external">image 4</a>) [<a href="#rid20">20</a>]. The systemic feeding vessel can be noted above, within, or below the diaphragm. Identifying a systemic fetal vessel is important in differential diagnosis because BPS usually receives its blood supply from a feeding vessel arising directly from the aorta, whereas CPAM receives its blood supply from the normal pulmonary vasculature, and hybrid BPS/CPAM receives its blood supply from both a feeding vessel arising from the aorta and from the normal pulmonary vasculature. However, even with thorough assessment, the vascular supply may not be visualized prenatally due to various factors including fetal lie, maternal obesity, and oligohydramnios [<a href="#rid9">9,21</a>]. </p><p>It is also important for surgical planning to specifically assess the supra-, intra-, or infra-diaphragmatic location of the mass, and to specify the origin of the feeding vessel. For example, if the vessel originates from an infra-diaphragmatic artery, and the mass is intralobar, the surgeon will need access to both the thoracic and abdominal cavities. </p><p class="headingAnchor" id="H1665505119"><span class="h3">Postdiagnostic imaging evaluation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fetal anatomic survey</strong> – Thorough assessment of the entire fetus is important to look for additional anomalies [<a href="#rid9">9,22</a>]. ILS is not associated with an increased risk of additional anomalies [<a href="#rid9">9,22</a>]. ELS is associated with anomalies in up to two-thirds of cases [<a href="#rid23">23</a>]. These anomalies include chest wall and vertebral anomalies, hindgut duplications, diaphragmatic hernia, congenital heart disease, and renal and intracranial abnormalities [<a href="#rid9">9,22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CVR</strong> – Quantitative ultrasound evaluation helps predict the prenatal course of BPS and includes measuring the congenital pulmonary airway malformation volume ratio (CVR). This is obtained by calculating the volume of the lung mass using the formula for the volume of a prolate ellipsoid and normalizing it by gestational age. To normalize by gestational age, the lung mass volume should be divided by the head circumference [<a href="#rid24">24</a>]: </p><p></p><div class="formulaContainer"><div class="formula"><p class="bulletIndent1">CVR = height x anteroposterior diameter x transverse diameter x 0.52 (constant)/head circumference </p></div></div><p></p><p class="bulletIndent1">The use of CVR allows direct comparison of fetuses of different gestational ages. In BPS, a CVR &gt;1.6 is associated with a higher risk for development of hydrops but does not uniformly result in hydrops; 58 percent of fetuses with a high CVR developed hydrops in one study [<a href="#rid25">25</a>]. Thus, CVR can be used to identify fetuses in need of closer follow-up. (See <a class="local">'Follow-up imaging'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Venous drainage</strong> – The venous draining pattern should be assessed, given systemic rather than pulmonary venous drainage is a poor prognostic factor and has been linked with outcome [<a href="#rid26">26</a>]. (See <a class="local">'Poor prognostic factors'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mediastinal shift, pleural effusions, hydrops</strong> – It is important to assess for mediastinal shift and pleural effusions/other signs of hydrops  (<a class="graphic graphic_diagnosticimage graphicRef105396" href="/d/graphic/105396.html" rel="external">image 6</a>), which generally require intervention. (See <a class="local">'Hydrops'</a> below and <a class="local">'Pleural effusion with mediastinal shift'</a> below.)</p><p></p><p class="headingAnchor" id="H31928907"><span class="h2">Role of magnetic resonance imaging</span><span class="headingEndMark"> — </span>MRI can be performed to confirm ultrasound diagnosis or in cases where the ultrasound is inconclusive or images are suboptimal (due to maternal body habitus, fetal lie, oligohydramnios). In either case, MRI can be of help to assess for associated extrathoracic anomalies that could change the prognosis. </p><p>In BPS, MRI typically reveals a hyperintense T2w mass often located in the lower lobe  (<a class="graphic graphic_diagnosticimage graphicRef105395" href="/d/graphic/105395.html" rel="external">image 7</a>) [<a href="#rid9">9,20,27</a>]. The feeding vessel may be a low signal line coursing from the aorta into the mass. MRI is also helpful for delineating the mass and its location (chest, diaphragm, or infradiaphragmatic), evaluating the contralateral lung, and assessing for other congenital abnormalities  (<a class="graphic graphic_diagnosticimage graphicRef143201" href="/d/graphic/143201.html" rel="external">image 8</a>) [<a href="#rid9">9,21</a>]. In a series of 103 fetal lung masses resected for suspected congenital lung malformations [<a href="#rid28">28</a>], ultrasound detected 85 (82.5 percent) lung lesions and correctly diagnosed whether or not a lesion was a CPAM in 75 percent of cases (sensitivity 93 percent, specificity 32 percent). MRI had a similar concordance rate for diagnosing CPAM (73 percent), but was superior in correctly determining whether a systemic feeding vessel was present (overall accuracy 80 percent, sensitivity 71 percent, specificity 88 percent) compared with ultrasound (overall accuracy 72 percent, sensitivity 49 percent, specificity 93 percent). </p><p>At times, a feeding vessel may not be identified prenatally by either ultrasound or MRI. In the series described above, postnatal computed tomography (CT) diagnosed whether a systemic feeding vessel was present in 90 percent of cases (sensitivity 92 percent, specificity 88 percent), which was superior to both prenatal ultrasound and MRI [<a href="#rid28">28</a>]. Thus, obtaining additional cross-sectional imaging postnatally with a contrast CT scan is typically recommended. However, performing a second fetal MRI late in gestation may add information to that obtained by an early MRI because MRI after 32 weeks of gestation can better identify the feeding vessel and has better correlation with postnatal imaging [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H31928913"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The prenatal differential diagnosis of bronchopulmonary sequestration (BPS) depends on whether it is intrathoracic or extrathoracic. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis of intrathoracic lesions includes:</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Congenital pulmonary airway malformation (CPAM)</strong> – Both microcystic CPAM and BPS appear solid and homogeneous on ultrasound and magnetic resonance imaging (MRI). Identification of a systemic arterial feeder helps differentiate BPS from microcystic CPAM, which connects to the normal pulmonary vasculature, although a hybrid lesion still could be present. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management"</a> and  <a class="medical medical_review" href="/d/html/6346.html" rel="external">"Congenital pulmonary airway malformation"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Congenital lobar overinflation (CLO)/congenital lobar emphysema (CLE)</strong> – The sonographic features of CLO include a bright echogenic lung with pulmonary arterial blood flow through the mass; cystic lesions may be present [<a href="#rid30">30</a>]. Prenatally, this diagnosis can be difficult to differentiate from microcystic CPAM and BPS. The presence of normal pulmonary vascularity through the mass excludes BPS and microcystic CPAM. The diagnosis is confirmed postnatally by computed tomography (CT), which shows emphysematous alveoli in CLO and distorted lung tissue in microcystic CPAM [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/6350.html" rel="external">"Congenital lobar emphysema"</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Congenital diaphragmatic hernia (CDH</strong>) – Herniated bowel loops in the hemithorax can mimic a multicystic, heterogeneous lung mass. Mediastinal and cardiac deviation may be the only hint that a CDH is present in the relatively rare instances where the stomach remains infradiaphragmatic. When the stomach is herniated into the hemithorax, nonvisualization of the stomach bubble within the abdomen is helpful for making the diagnosis [<a href="#rid9">9,22</a>]. Peristalsis of bowel loops in the thorax can sometimes be seen by ultrasound [<a href="#rid9">9</a>]. Deviation of the umbilical portion of the portal vein suggests liver herniation into the thorax. Direct visualization of hepatic vessels extending into the chest confirms liver in the thoracic cavity. MRI is particularly useful in assessing the amount of liver herniation and delineation of small and large meconium-filled bowel in the chest. Meconium is dark on T2 and bright on T1, while liver is bright on T1w and intermediate on T2w, thus easily differentiated from adjacent lung. (See  <a class="medical medical_review" href="/d/html/6800.html" rel="external">"Congenital diaphragmatic hernia: Prenatal issues"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lung tumors</strong> – Though rare, malignancies such as pleuropulmonary blastoma can present as an asymptomatic congenital lung lesion. In a retrospective postnatal study involving 99 asymptomatic congenital lung lesions with 91 diagnosed prenatally, only 2 percent consisted of tumors [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis of extrathoracic lesions includes:</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neuroblastoma</strong> – Neuroblastoma, as well as other intraabdominal masses, such as mesoblastic nephroma, can mimic an infradiaphragmatic BPS. Thorough examination to assess origin can help differentiate between these lesions: mesoblastic nephroma arises from the kidney, is most common on the right side, and can be cystic [<a href="#rid9">9</a>], whereas BPS is more common on the left and appears solid.</p><p></p><p class="bulletIndent2">Neuroblastoma is often diagnosed in the third trimester and tends to grow over time, while BPS is more often identified in the second trimester and tends to regress over time [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/d/html/6810.html" rel="external">"Fetal abdomen: Differential diagnosis of abnormal echogenicity and calcification", section on 'Neuroblastoma'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Adrenal hemorrhage</strong> – In contrast to BPS, the key to diagnosis of adrenal hemorrhage is the change in appearance over time. The initial appearance is that of an echogenic and solid-appearing lesion without internal blood flow. Subsequently, a hypoechoic central region develops, and then a more cystic appearance and a decrease in size are observed. Dystrophic calcifications may develop. On MRI, hemosiderin may be seen in a hemorrhage. </p><p></p><p class="bulletIndent2">In addition, BPS has a systemic feeding vessel and is diagnosed in the second trimester whereas adrenal hemorrhage typically occurs in the third trimester and has no feeding vessel. (See  <a class="medical medical_review" href="/d/html/6810.html" rel="external">"Fetal abdomen: Differential diagnosis of abnormal echogenicity and calcification", section on 'Adrenal hemorrhage'</a>.)</p><p></p><p class="headingAnchor" id="H31928949"><span class="h1">PRENATAL COURSE</span><span class="headingEndMark"> — </span>Bronchopulmonary sequestration (BPS) is usually a small lesion relative to the chest and decreases in size in late gestation in approximately 75 percent of cases [<a href="#rid9">9,20,33</a>]. The apparent resolution has been attributed to decompression into the normal lung, overgrowth with respect to the amount of blood supplied by the systemic circulation, or torsion around the vascular pedicle resulting in vascular and lymphatic obstruction [<a href="#rid9">9</a>]. Although torsion has been associated with size regression, a case of mass torsion with impaired venous return from the mass leading to tension hydrothorax, heart/mediastinal compression, and hydrops has also been described [<a href="#rid34">34</a>]. </p><p></p><p>As BPS regresses, the lesion becomes more difficult to visualize on ultrasound. On MRI, it initially has similar signal intensity to the adjacent lung and then becomes darker than adjacent lung when it is almost completely collapsed/resolved. Masses that appeared to resolve in utero are typically found on postnatal computed tomography (CT) [<a href="#rid35">35,36</a>]. </p><p>In a series of 103 fetuses with intralobar sequestration (ILS) (n = 44) and extralobar sequestration (ELS) (n = 59) managed at a single institution, 94 percent of ILS and 71 percent of ELS decreased in size or became isoechoic compared with the normal adjacent lung parenchyma from initial to final evaluation [<a href="#rid37">37</a>]. Lesions achieved their peak size at 26 to 28 weeks of gestation. </p><p class="headingAnchor" id="H3224779332"><span class="h2">Poor prognostic factors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ELS</strong> has a poorer prognosis than ILS. In one series, hydrothorax only developed in fetuses with ELS, and four of these eight cases also developed hydrops [<a href="#rid37">37</a>]. All 103 fetuses survived; 41/44 ILS (93 percent) and 35/59 ELS (59 percent) were resected postnatally. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Large lesions</strong> have a poorer prognosis than small lesions. When BPS presents as a large intrathoracic mass (which can be defined by CVR &gt;1.6), mediastinal shift can occur, placing the fetus at risk of compression of the heart, thoracic venous structures, and esophagus, resulting in large pleural effusions that may progress to hydrops and may be associated with polyhydramnios [<a href="#rid9">9,33,38</a>]. Hydrops can also result from shunting when there is a systemic arterial feeder and the mass drains via the pulmonary circulation. However, large lesions with mediastinal shift, cardiac dextroposition, or cardiac compression do not always cause hydrops [<a href="#rid21">21</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic drainage</strong> is more common in ELS than ILS and systemic rather than pulmonary venous drainage is another poor prognostic factor. In a study of 71 fetuses with BPS, fetuses with systemic venous drainage had a higher incidence of associated anomalies, hydrops, and polyhydramnios compared with those with a pulmonary venous drainage [<a href="#rid26">26</a>]. </p><p></p><p class="headingAnchor" id="H31928955"><span class="h1">ROUTINE OBSTETRIC MANAGEMENT</span><span class="headingEndMark"> — </span>In addition to routine prenatal care, we suggest the following.</p><p class="headingAnchor" id="H4288203881"><span class="h2">Genetic counseling</span><span class="headingEndMark"> — </span>The incidence of chromosomal abnormalities is not increased above baseline in fetuses with bronchopulmonary sequestration (BPS) alone; this should be considered when weighing the risks and benefits of invasive procedures for prenatal diagnostic genetic studies. If performed, microarray is preferable to a karyotype and should be offered in cases with associated anomalies, as the frequency of genetic abnormalities is increased in fetuses with additional anomalies [<a href="#rid39">39-45</a>] and/or nonimmune hydrops [<a href="#rid46">46</a>]. (See  <a class="medical medical_review" href="/d/html/104101.html" rel="external">"Prenatal genetic evaluation of the fetus with anomalies or soft markers"</a>.)</p><p class="headingAnchor" id="H1270047014"><span class="h2">Parental counseling</span><span class="headingEndMark"> — </span>Parental counseling includes:</p><p class="bulletIndent1"><span class="glyph">●</span>The differential diagnosis of prenatally suspected BPS. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The possible prenatal course of the BPS. If diagnosed in the second trimester, the mass can continue to grow and hydrops may develop. There are no reliable criteria for determining which lesions will grow and thus potentially lead to development of hydrops versus those that will stabilize or regress in size and thus have minimal fetal impact. In general, a fetus with a large BPS (defined by congenital pulmonary airway malformation volume ratio [CVR] &gt;1.6) who develops hydrops in the second trimester is likely to have a poor prognosis (eg, fetal demise, very or extremely preterm birth, pulmonary hypoplasia). By comparison, if a small BPS is diagnosed at the end of the second trimester or in the third trimester, subsequent development of hydrops is unlikely and the prognosis is good. (See <a class="local">'Prenatal course'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The potential need for and the options for prenatal intervention (eg, thoracoamniotic shunt, laser ablation, sclerotic treatment and steroids, and early delivery). (See <a class="local">'Pleural effusion with mediastinal shift'</a> below and <a class="local">'Hydrops'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Choosing an appropriate site for planned delivery, with consideration of the need for resources for newborn resuscitation and surgery. (See <a class="local">'Delivery'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postnatal issues (clinical manifestations, postnatal evaluation, postnatal management, potential complications, prognosis of associated anomalies, and range of outcomes). (See  <a class="medical medical_review" href="/d/html/6341.html" rel="external">"Bronchopulmonary sequestration"</a>.)</p><p></p><p class="headingAnchor" id="H2592111431"><span class="h2">Follow-up imaging</span><span class="headingEndMark"> — </span>All patients should have serial prenatal follow-up ultrasound examinations to assess change in size of the lung mass and development of hydrops [<a href="#rid9">9</a>]. The frequency depends on the size of the lesion and gestational age at diagnosis; larger lesions should be followed more closely. Although follow-up ultrasound might not identify the lung lesion since BPS can acquire the same echogenicity of adjacent normal lung, assessment for hydrops and mediastinal shift is still possible.</p><p>We suggest serial prenatal follow-up ultrasound examinations every one to four weeks, similar to the protocols recommended for congenital pulmonary airway malformation (CPAM) [<a href="#rid24">24</a>]. The frequency within this range depends on the gestational age and CVR. </p><p class="bulletIndent1"><span class="glyph">●</span>Closer follow-up should be performed in those patients with CVR ≥1.6 and &lt;26 weeks as they are at high risk of developing hydrops. In these cases, consultation with a maternal fetal medicine (MFM) specialist for medical intervention is appropriate. When incipient hydrops is suspected, assessment every two to three days is reasonable. Depending on gestational age and severity of hydrops, consultation for fetal surgical intervention should be considered. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Conversely, the interval between studies can be lengthened in patients with CVR &lt;0.91 [<a href="#rid47">47</a>] and in whom BPS growth has plateaued or is regressing, especially after 30 weeks of gestation [<a href="#rid48">48</a>]. A decrease in mass area/head circumference or mass volume/estimated fetal weight ratio is associated with regression [<a href="#rid49">49</a>]. </p><p></p><p class="headingAnchor" id="H4267932851"><span class="h1">MANAGEMENT OF COMPLICATED CASES</span></p><p class="headingAnchor" id="H3115388380"><span class="h2">Hybrid BPS/CPAM</span><span class="headingEndMark"> — </span>Macrocysts within bronchopulmonary sequestration (BPS) are consistent with a hybrid lesion (BPS with macrocystic congenital pulmonary airway malformation [CPAM]). The management of hybrid lesions, which may include maternal <a class="drug drug_general" data-topicid="9139" href="/d/drug information/9139.html" rel="external">betamethasone</a> therapy and cyst drainage, is based on the CPAM component and described separately. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management"</a>.)</p><p class="headingAnchor" id="H3322612236"><span class="h2">Hydrops</span><span class="headingEndMark"> — </span>Hydrops is uncommon [<a href="#rid38">38</a>], but it is a sign of impending fetal demise and thus an indication for intervention [<a href="#rid27">27</a>]. However, management of these complex cases must be individualized based on gestational age, severity of hydrops, available resources, and shared decision-making.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>≥32 to 34 weeks of gestation</strong> – For pregnancies greater than 32 to 34 weeks of gestation, delivery with immediate postnatal resection is a reasonable option, especially with increasing severity of hydrops [<a href="#rid33">33</a>], given that newborn mortality (and morbidity) substantially decreases after 32 and particularly after 34 weeks of gestation [<a href="#rid50">50</a>]. (See  <a class="medical medical_review" href="/d/html/4966.html" rel="external">"Preterm birth: Definitions of prematurity, epidemiology, and risk factors for infant mortality", section on 'Birth weight and gestational age'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>20 and 32 weeks</strong> – For pregnancies between 20 and 32 weeks, fetal therapy in an attempt to improve fetal hemodynamics, reverse hydrops (and prevent pulmonary hypoplasia), and allow further in utero maturation is generally preferable to very preterm birth, which has high mortality and morbidity. Several interventions have been described and appear to improve survival [<a href="#rid36">36</a>]. Invasive interventions should only be undertaken at centers experienced in fetal surgery. Prenatal intervention requires extensive parental counseling on the potential risks versus benefits of surgery. The procedures are investigational and have not been compared in randomized trials.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The most common intervention is thoracentesis or thoracoamniotic shunt placement. In fetuses under 30 weeks of gestation, a thoracoamniotic shunt may be preferred to avoid the need for repeated thoracenteses.   </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In a series including four fetuses with extralobar sequestration (ELS), tension hydrothorax, and secondary hydrops, hydrops resolved after serial thoracenteses in one fetus and after thoracoamniotic shunt placement in two fetuses; all three neonates underwent resection of the lesion after delivery in the mid to late third trimester [<a href="#rid33">33</a>]. The fourth hydropic fetus was not treated in utero and died of pulmonary hypoplasia after a prolonged neonatal course. The shunting procedure and complications are similar to those in CPAM. Potential complications include displacement or malfunction of the catheter, thrombus occlusion of the catheter, fatal fetal hemorrhage, procedure-related placental abruption, preterm prelabor rupture of membranes, and preterm labor [<a href="#rid51">51-53</a>]. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management", section on 'Second-line therapy: Invasive procedures'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In a series of four cases of ELS with hydrops, maternal <a class="drug drug_general" data-topicid="9139" href="/d/drug information/9139.html" rel="external">betamethasone</a> was administered and three also underwent thoracentesis and/or thoracoamniotic shunt placement, with subsequent resolution of hydrops [<a href="#rid37">37</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Percutaneous laser ablation of the feeding vessel has been reported to decrease tumor size, allow growth of normal lung parenchyma, and reverse pleural effusion or hydrops in over 75 percent of cases reported in several small studies [<a href="#rid8">8,54-59</a>]; it also decreases the need for postnatal sequestrectomy, as infants are often asymptomatic [<a href="#rid60">60</a>]. Sometimes two procedures are necessary [<a href="#rid8">8</a>] and a postnatal intervention could be required to remove the residual sequestration [<a href="#rid61">61</a>]. In a retrospective study that compared shunt placement with intrafetal vascular laser ablation for treatment of BPS with pleural effusion, complete regression of the lesion occurred more often with laser ablation (four of five completely regressed) than with shunt placement (zero of seven completely regressed), and gestational age at birth was lower with shunt placement (37.2 versus 39.1 weeks) [<a href="#rid58">58</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Radiofrequency ablation has also been safely used in a fetus with significant pleural effusion, mediastinal shift, and secondary lung collapse [<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Percutaneous ultrasound-guided fetal sclerotherapy has also been described [<a href="#rid63">63</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>One in utero open resection has been successfully performed to salvage a hydropic fetus remote from term [<a href="#rid54">54</a>]. This infant had good pulmonary function and development at 20 months of age. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Two case reports described favorable effects (resolution of hydrops, resolution of pleural effusion) after <a class="drug drug_general" data-topicid="9139" href="/d/drug information/9139.html" rel="external">betamethasone</a> therapy [<a href="#rid64">64,65</a>].</p><p></p><p class="headingAnchor" id="H3659401338"><span class="h2">Pleural effusion with mediastinal shift</span><span class="headingEndMark"> — </span>The fetus with BPS rarely develops a pleural effusion with mediastinal shift. If tension hydrothorax or cardiac decompensation with hydrops develops, thoracoamniotic shunting may be considered as a temporizing maneuver (similar to cases with CPAM). Resolution of hydrops after in utero therapy is predictive of postnatal survival [<a href="#rid33">33,51,66,67</a>]. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management", section on 'Second-line therapy: Invasive procedures'</a>.)</p><p class="headingAnchor" id="H31928961"><span class="h1">DELIVERY</span><span class="headingEndMark"> — </span>Delivery planning should be in conjunction with the pediatric staff (neonatology, pediatric surgery). </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing and route</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If the lung mass has resolved or is small with no mediastinal shift or hydrops, bronchopulmonary sequestration (BPS) itself is not an indication for early delivery or cesarean birth [<a href="#rid51">51</a>]. Neonatal respiratory problems would be unlikely. A CVR &lt;1.1 has been used to select patients who can safely give birth at their hospital of choice, even if the facility does not have resources for intensive neonatal care [<a href="#rid68">68</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For fetuses with large masses that cause mediastinal shift and/or hydrops, delivery should be planned for a tertiary care center with an intensive care nursery capable of resuscitation of a neonate with respiratory difficulties, including and with pediatric surgeons experienced in care of these infants [<a href="#rid66">66,69</a>]. (See <a class="local">'Hydrops'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of EXIT</strong> – Rare fetuses may benefit from availability of EXIT. In EXIT, the fetus is partially delivered and intubated without clamping the umbilical cord. Uteroplacental blood flow and gas exchange are maintained by using inhalational agents to provide uterine relaxation, and amnioinfusion is performed to maintain uterine volume. EXIT is not usually helpful for isolated BPS because of the absence of a connection between the abnormal lung and the normal bronchial tree. However, a fetus with hybrid BPS/congenital pulmonary airway malformation (CPAM) with a large CPAM component and systemic feeding vessel may benefit as lung parenchyma may fill with air and not decompress. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management", section on 'Ex utero intrapartum therapy (EXIT) procedure'</a>.) </p><p></p><p class="headingAnchor" id="H31928967"><span class="h1">POSTNATAL MANAGEMENT</span><span class="headingEndMark"> — </span>Postnatal presentation, evaluation, complications, and management are discussed separately. (See  <a class="medical medical_review" href="/d/html/6341.html" rel="external">"Bronchopulmonary sequestration"</a>.)</p><p class="headingAnchor" id="H31928973"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomy</strong> – Bronchopulmonary sequestration (BPS) consists of a nonfunctioning mass of lung tissue that lacks normal communication with the tracheobronchial tree and receives its blood supply from the systemic circulation (rather than the pulmonary circulation, which would be seen with congenital pulmonary airway malformation [CPAM]). The feeding vessel most commonly originates from the thoracic aorta, but origin from the abdominal aorta or its divisions can also occur. BPS is classified anatomically as intralobar (ILS) or extralobar (ELS), which are histologically similar, but have different locations and often different venous drainage and prognosis. (See <a class="local">'Anatomic and epidemiologic features of BPS'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prenatal diagnosis</strong> – The sonographic diagnosis of BPS is based on its typical appearance of a solid, triangular, echogenic usually unilateral mass, which is often located in the lower hemithorax adjacent to the diaphragm or within leaves of the diaphragm, or subdiaphragmatic. A necessary feature for diagnosis is identification of a feeding systemic artery to the mass. Hybrid BPS and CPAM lesions can occur and are characterized by both solid and cystic components in a lung mass with a systemic feeding artery. (See <a class="local">'Diagnostic findings'</a> above.)</p><p></p><p class="bulletIndent1">The systemic feeding vessel is not always identified on prenatal imaging. Magnetic resonance imaging (MRI) can be a useful adjunct in demonstrating the systemic feeding vessel when ultrasound imaging is limited by maternal body habitus, oligohydramnios, or fetal lie, but MRI is not 100 percent sensitive in vessel identification. (See <a class="local">'Role of magnetic resonance imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of thoracic BPS includes CPAM, congenital lobar emphysema, and congenital diaphragmatic hernia. When intraabdominal, BPS can mimic adrenal hemorrhage, neuroblastoma and mesoblastic nephroma. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prenatal course </strong>– BPS is usually a small lesion relative to the chest, enlarges during the second trimester to a peak size at 26 to 28 weeks of gestation, and then decreases in size in late gestation in approximately 75 percent of cases. Although some masses appear to resolve in utero, they are typically detected on postnatal computed tomography. </p><p></p><p class="bulletIndent1">Prognosis is typically very good in the absence of mediastinal shift, large pleural effusions, hydrops, and associated anomalies. Poor prognostic factors include ELS (which has a higher risk of associated anomalies and torsion), large lesions (which can be defined by CVR &gt;1.6 and can cause cardiac, vascular, and esophageal compression), systemic venous drainage, and hydrops. (See <a class="local">'Prenatal course'</a> above and <a class="local">'Poor prognostic factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postdiagnostic evaluation</strong> – Initial evaluation should include assessment for other congenital anomalies. The incidence of chromosomal abnormalities is not increased above baseline in fetuses with BPS alone, but microarray can be offered for further evaluation, and should be offered in cases with associated anomalies, as the frequency of genetic abnormalities is increased in fetuses with additional anomalies and/or nonimmune hydrops. (See <a class="local">'Genetic counseling'</a> above.)</p><p></p><p class="bulletIndent1">We suggest serial prenatal follow-up ultrasound examinations every one to four weeks to assess change in size of the lung mass and development of hydrops. The frequency within this range depends on the gestational age and congenital pulmonary airway malformation volume ratio (CVR). Closer follow-up should be performed in those patients with CVR ≥1.6 and &lt;26 weeks as they are at high risk of developing hydrops. When incipient hydrops is suspected, assessment every two to three days is reasonable. On the other hand, the interval between studies can be lengthened in patients with CVR &lt;0.91 and in whom BPS growth has plateaued or is regressing, especially after 30 weeks. (See <a class="local">'Follow-up imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of hydrops</strong> – Management of these complex cases must be individualized based on gestational age, severity of hydrops, available resources, and shared decision-making. (See <a class="local">'Hydrops'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For hydropic fetuses greater than 32 to 34 weeks of gestation, delivery with immediate postnatal resection is a reasonable option, given that newborn mortality (and morbidity) substantially decreases after 32 and particularly after 34 weeks of gestation. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For hydropic fetuses between 20 and 32 weeks, several interventions with the goal of improving fetal hemodynamics, reversing hydrops (and preventing pulmonary hypoplasia), and enabling further in utero maturation have been described and appear to improve survival. Invasive interventions should only be undertaken at centers experienced in fetal surgery. The most common intervention is thoracentesis or thoracoamniotic shunt placement. Other in-utero interventions include laser or radiofrequency ablation, sclerotherapy, and open resection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Delivery</strong> – Delivery planning should be in conjunction with the pediatric staff (neonatology, pediatric surgery). If the lung mass has resolved or is small with no mediastinal shift or hydrops, BPS itself is not an indication for early delivery or cesarean birth. Neonatal respiratory problems would be unlikely. For fetuses with large masses that cause mediastinal shift and/or hydrops, delivery should be planned at a tertiary care center with an intensive care nursery capable of resuscitation of a neonate with respiratory difficulties, including and with pediatric surgeons experienced in care of these infants. (See <a class="local">'Delivery'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gupta K, Das A, Menon P, et al. Revisiting the histopathologic spectrum of congenital pulmonary developmental disorders. Fetal Pediatr Pathol 2012; 31:74.</a></li><li><a class="nounderline abstract_t">Panicek DM, Heitzman ER, Randall PA, et al. The continuum of pulmonary developmental anomalies. Radiographics 1987; 7:747.</a></li><li><a class="nounderline abstract_t">Abbey P, Narula MK, Anand R. Congenital Malformations and Developmental Anomalies of the Lung. Curr Radiol Rep 2014; 2:71.</a></li><li><a class="nounderline abstract_t">Nunes C, Pereira I, Araújo C, et al. Fetal bronchopulmonary malformations. J Matern Fetal Neonatal Med 2015; 28:1996.</a></li><li><a class="nounderline abstract_t">Vijayaraghavan SB, Rao PS, Selvarasu CD, Rao TM. Prenatal sonographic features of intralobar bronchopulmonary sequestration. J Ultrasound Med 2003; 22:541.</a></li><li><a class="nounderline abstract_t">PRYCE DM. Lower accessory pulmonary artery with intralobar sequestration of lung; a report of seven cases. J Pathol Bacteriol 1946; 58:457.</a></li><li><a class="nounderline abstract_t">Gomez L, Robert JA, Sepulveda W. Fetal retroperitoneal pulmonary sequestration with an atypical vascular pattern. Prenat Diagn 2009; 29:290.</a></li><li><a class="nounderline abstract_t">Cruz-Martinez R, Méndez A, Dueñas-Riaño J, et al. Fetal laser surgery prevents fetal death and avoids the need for neonatal sequestrectomy in cases with bronchopulmonary sequestration. Ultrasound Obstet Gynecol 2015; 46:627.</a></li><li><a class="nounderline abstract_t">Azizkhan RG, Crombleholme TM. Congenital cystic lung disease: contemporary antenatal and postnatal management. Pediatr Surg Int 2008; 24:643.</a></li><li><a class="nounderline abstract_t">Abbey P, Das CJ, Pangtey GS, et al. Imaging in bronchopulmonary sequestration. J Med Imaging Radiat Oncol 2009; 53:22.</a></li><li><a class="nounderline abstract_t">Zobel M, Gologorsky R, Lee H, Vu L. Congenital lung lesions. Semin Pediatr Surg 2019; 28:150821.</a></li><li><a class="nounderline abstract_t">Epelman M, Kreiger PA, Servaes S, et al. Current imaging of prenatally diagnosed congenital lung lesions. Semin Ultrasound CT MR 2010; 31:141.</a></li><li><a class="nounderline abstract_t">Nijagal A, Jelin E, Feldstein VA, et al. The diagnosis and management of intradiaphragmatic extralobar pulmonary sequestrations: a report of 4 cases. J Pediatr Surg 2012; 47:1501.</a></li><li><a class="nounderline abstract_t">Houda el M, Ahmed Z, Amine K, et al. Antenatal diagnosis of extralobar pulmonar sequestration. Pan Afr Med J 2014; 19:54.</a></li><li><a class="nounderline abstract_t">Maki E, Oh K, Rogers S, Sohaey R. Imaging and differential diagnosis of suprarenal masses in the fetus. J Ultrasound Med 2014; 33:895.</a></li><li><a class="nounderline abstract_t">Chouikh T, Berteloot L, Revillon Y, et al. Extralobar pulmonary sequestration with combined gastric and intradiaphragmatic locations. Pediatr Pulmonol 2014; 49:512.</a></li><li><a class="nounderline abstract_t">Bulas D. Fetal magnetic resonance imaging as a complement to fetal ultrasonography. Ultrasound Q 2007; 23:3.</a></li><li><a class="nounderline abstract_t">Pacharn P, Kline-Fath B, Calvo-Garcia M, et al. Congenital lung lesions: prenatal MRI and postnatal findings. Pediatr Radiol 2013; 43:1136.</a></li><li><a class="nounderline abstract_t">Maas KL, Feldstein VA, Goldstein RB, Filly RA. Sonographic detection of bilateral fetal chest masses: report of three cases. J Ultrasound Med 1997; 16:647.</a></li><li><a class="nounderline abstract_t">Hubbard AM, Adzick NS, Crombleholme TM, et al. Congenital chest lesions: diagnosis and characterization with prenatal MR imaging. Radiology 1999; 212:43.</a></li><li><a class="nounderline abstract_t">Sepulveda W. Perinatal imaging in bronchopulmonary sequestration. J Ultrasound Med 2009; 28:89.</a></li><li><a class="nounderline abstract_t">Bush A, Hogg J, Chitty LS. Cystic lung lesions - prenatal diagnosis and management. Prenat Diagn 2008; 28:604.</a></li><li><a class="nounderline abstract_t">Gerle RD, Jaretzki A 3rd, Ashley CA, Berne AS. Congenital bronchopulmonary-foregut malformation. Pulmonary sequestration communicating with the gastrointestinal tract. N Engl J Med 1968; 278:1413.</a></li><li><a class="nounderline abstract_t">Crombleholme TM, Coleman B, Hedrick H, et al. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung. J Pediatr Surg 2002; 37:331.</a></li><li><a class="nounderline abstract_t">Zhang H, Tian J, Chen Z, et al. Retrospective study of prenatal diagnosed pulmonary sequestration. Pediatr Surg Int 2014; 30:47.</a></li><li><a class="nounderline abstract_t">Lin MF, Xie HN, Zhao XH, et al. Systemic Venous Drainage Is Associated with an Unfavorable Prenatal Behavior in Fetal Bronchopulmonary Sequestration. Fetal Diagn Ther 2018; 44:291.</a></li><li><a class="nounderline abstract_t">Daltro P, Werner H, Gasparetto TD, et al. Congenital chest malformations: a multimodality approach with emphasis on fetal MR imaging. Radiographics 2010; 30:385.</a></li><li><a class="nounderline abstract_t">Mon RA, Johnson KN, Ladino-Torres M, et al. Diagnostic accuracy of imaging studies in congenital lung malformations. Arch Dis Child Fetal Neonatal Ed 2019; 104:F372.</a></li><li><a class="nounderline abstract_t">Flanagan S, Rubesova E, Hintz S, et al. Prenatal imaging of bronchopulmonary malformations: Is there a role for late third trimester fetal MRI? Pediatr Radiol 2013; 43:205.</a></li><li><a class="nounderline abstract_t">Pariente G, Aviram M, Landau D, Hershkovitz R. Prenatal diagnosis of congenital lobar emphysema: case report and review of the literature. J Ultrasound Med 2009; 28:1081.</a></li><li><a class="nounderline abstract_t">Zeidan S, Gorincour G, Potier A, et al. Congenital lung malformation: evaluation of prenatal and postnatal radiological findings. Respirology 2009; 14:1005.</a></li><li><a class="nounderline abstract_t">Durell J, Thakkar H, Gould S, et al. Pathology of asymptomatic, prenatally diagnosed cystic lung malformations. J Pediatr Surg 2016; 51:231.</a></li><li><a class="nounderline abstract_t">Adzick NS, Harrison MR, Crombleholme TM, et al. Fetal lung lesions: management and outcome. Am J Obstet Gynecol 1998; 179:884.</a></li><li><a class="nounderline abstract_t">Coleman AM, Merrow AC, Crombleholme TM, et al. Fetal MRI of Torsed Bronchopulmonary Sequestration with Tension Hydrothorax and Hydrops in a Twin Gestation. Fetal Diagn Ther 2016; 40:156.</a></li><li><a class="nounderline abstract_t">Breysem L, Bosmans H, Dymarkowski S, et al. The value of fast MR imaging as an adjunct to ultrasound in prenatal diagnosis. Eur Radiol 2003; 13:1538.</a></li><li><a class="nounderline abstract_t">Lecomte B, Hadden H, Coste K, et al. Hyperechoic congenital lung lesions in a non-selected population: from prenatal detection till perinatal management. Prenat Diagn 2009; 29:1222.</a></li><li><a class="nounderline abstract_t">Riley JS, Urwin JW, Oliver ER, et al. Prenatal growth characteristics and pre/postnatal management of bronchopulmonary sequestrations. J Pediatr Surg 2018; 53:265.</a></li><li><a class="nounderline abstract_t">Grethel EJ, Wagner AJ, Clifton MS, et al. Fetal intervention for mass lesions and hydrops improves outcome: a 15-year experience. J Pediatr Surg 2007; 42:117.</a></li><li><a class="nounderline abstract_t">Staebler M, Donner C, Van Regemorter N, et al. Should determination of the karyotype be systematic for all malformations detected by obstetrical ultrasound? Prenat Diagn 2005; 25:567.</a></li><li><a class="nounderline abstract_t">Halliday J, Lumley J, Bankier A. Karyotype abnormalities in fetuses diagnosed as abnormal on ultrasound before 20 weeks' gestational age. Prenat Diagn 1994; 14:689.</a></li><li><a class="nounderline abstract_t">van Zalen-Sprock MM, van Vugt JM, Karsdorp VH, et al. Ultrasound diagnosis of fetal abnormalities and cytogenetic evaluation. Prenat Diagn 1991; 11:655.</a></li><li><a class="nounderline abstract_t">Nicolaides KH, Snijders RJ, Gosden CM, et al. Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 1992; 340:704.</a></li><li><a class="nounderline abstract_t">Rizzo N, Pittalis MC, Pilu G, et al. Distribution of abnormal karyotypes among malformed fetuses detected by ultrasound throughout gestation. Prenat Diagn 1996; 16:159.</a></li><li><a class="nounderline abstract_t">Bijok J, Massalska D, Kucińska-Chahwan A, et al. Complex malformations involving the fetal body wall - definition and classification issues. Prenat Diagn 2017; 37:1033.</a></li><li><a class="nounderline abstract_t">Huang Q, Zhang Y, Jing X, et al. Association of prenatal thoracic ultrasound abnormalities with copy number variants at a single Chinese tertiary center. Int J Gynaecol Obstet 2024; 164:770.</a></li><li><a class="nounderline abstract_t">Deng Q, Fu F, Yu Q, et al. Nonimmune hydrops fetalis: Genetic analysis and clinical outcome. Prenat Diagn 2020; 40:803.</a></li><li><a class="nounderline abstract_t">Hellmund A, Berg C, Geipel A, et al. Prenatal Diagnosis and Evaluation of Sonographic Predictors for Intervention and Adverse Outcome in Congenital Pulmonary Airway Malformation. PLoS One 2016; 11:e0150474.</a></li><li><a class="nounderline abstract_t">Coleman BG, Adzick NS, Crombleholme TM, et al. Fetal therapy: state of the art. J Ultrasound Med 2002; 21:1257.</a></li><li><a class="nounderline abstract_t">Pinto RM, Araujo Júnior E, Augusto LC, et al. Spontaneous regression of intralobar pulmonary sequestration during the pregnancy: report of two cases through relationships between mass and fetal biometry and review of the literature. J Matern Fetal Neonatal Med 2016; 29:1720.</a></li><li><a class="nounderline abstract_t">Ely DM, Driscoll AK. Infant Mortality in the United States, 2017: Data From the Period Linked Birth/Infant Death File. Natl Vital Stat Rep 2019; 68:1.</a></li><li><a class="nounderline abstract_t">Wilson RD. In utero therapy for fetal thoracic abnormalities. Prenat Diagn 2008; 28:619.</a></li><li><a class="nounderline abstract_t">Nassr AA, Ruano R, Espinoza J, Shamshirsaz AA. Successful in utero Percutaneous Fetoscopic Release of a Wrapped Pleuro-Amniotic Shunt around the Fetal Arm: Case Report and Review of the Literature. Fetal Diagn Ther 2018; 43:156.</a></li><li><a class="nounderline abstract_t">Belfort MA, Shamshirsaz AA, Whitehead WE, et al. Unusual pleuroamniotic shunt complication managed using a two-port in-CO2 fetoscopic technique: technical and ethical considerations. Ultrasound Obstet Gynecol 2016; 47:123.</a></li><li><a class="nounderline abstract_t">Mychaliska GB, Bryner BS, Nugent C, et al. Giant pulmonary sequestration: the rare case requiring the EXIT procedure with resection and ECMO. Fetal Diagn Ther 2009; 25:163.</a></li><li><a class="nounderline abstract_t">Witlox RS, Lopriore E, Walther FJ, et al. Single-needle laser treatment with drainage of hydrothorax in fetal bronchopulmonary sequestration with hydrops. Ultrasound Obstet Gynecol 2009; 34:355.</a></li><li><a class="nounderline abstract_t">Oepkes D, Devlieger R, Lopriore E, Klumper FJ. Successful ultrasound-guided laser treatment of fetal hydrops caused by pulmonary sequestration. Ultrasound Obstet Gynecol 2007; 29:457.</a></li><li><a class="nounderline abstract_t">Ruano R, de A Pimenta EJ, Marques da Silva M, et al. Percutaneous intrauterine laser ablation of the abnormal vessel in pulmonary sequestration with hydrops at 29 weeks' gestation. J Ultrasound Med 2007; 26:1235.</a></li><li><a class="nounderline abstract_t">Mallmann MR, Geipel A, Bludau M, et al. Bronchopulmonary sequestration with massive pleural effusion: pleuroamniotic shunting vs intrafetal vascular laser ablation. Ultrasound Obstet Gynecol 2014; 44:441.</a></li><li><a class="nounderline abstract_t">Ruano R, da Silva MM, Salustiano EM, et al. Percutaneous laser ablation under ultrasound guidance for fetal hyperechogenic microcystic lung lesions with hydrops: a single center cohort and a literature review. Prenat Diagn 2012; 32:1127.</a></li><li><a class="nounderline abstract_t">Gottschalk I, Strizek B, Mallmann MR, et al. Outcome of Bronchopulmonary Sequestration with Massive Pleural Effusion after Intrafetal Vascular Laser Ablation. Fetal Diagn Ther 2018; 44:149.</a></li><li><a class="nounderline abstract_t">Fusi G, Sartor A, Groussolles M, et al. Successful Elective Thoracoscopic Resection of Complicate Extralobar Bronchopulmonary Sequestration after Intrafoetal Vascular Laser Ablation: The Paediatric Surgeon's Point of View. Case Rep Pediatr 2023; 2023:4959022.</a></li><li><a class="nounderline abstract_t">Dadhwal V, Sharma KA, Sahay N, et al. Successful Treatment of Bronchopulmonary Sequestration by Radiofrequency Ablation of Feeding Artery. Fetal Diagn Ther 2022; 49:502.</a></li><li><a class="nounderline abstract_t">Bermúdez C, Pérez-Wulff J, Bufalino G, et al. Percutaneous ultrasound-guided sclerotherapy for complicated fetal intralobar bronchopulmonary sequestration. Ultrasound Obstet Gynecol 2007; 29:586.</a></li><li><a class="nounderline abstract_t">Pock R, Straňák Z, Vojtěch J, et al. Bronchopulmonary Sequestration with Fetal Hydrops in a Monochorionic Twin Successfully Treated with Multiple Courses of Betamethasone. AJP Rep 2018; 8:e359.</a></li><li><a class="nounderline abstract_t">Guenot C, Dubrit K, Lepigeon K, et al. Effect of maternal betamethasone on hydrops fetalis caused by extralobar pulmonary sequestration: a case report. J Obstet Gynaecol 2019; 39:120.</a></li><li><a class="nounderline abstract_t">Mann S, Wilson RD, Bebbington MW, et al. Antenatal diagnosis and management of congenital cystic adenomatoid malformation. Semin Fetal Neonatal Med 2007; 12:477.</a></li><li><a class="nounderline abstract_t">Knox EM, Kilby MD, Martin WL, Khan KS. In-utero pulmonary drainage in the management of primary hydrothorax and congenital cystic lung lesion: a systematic review. Ultrasound Obstet Gynecol 2006; 28:726.</a></li><li><a class="nounderline abstract_t">Mehl SC, Short WD, Kinley A, et al. Delivery planning for congenital lung malformations: A CVR based perinatal care algorithm. J Pediatr Surg 2022; 57:833.</a></li><li><a class="nounderline abstract_t">Adzick NS. Open fetal surgery for life-threatening fetal anomalies. Semin Fetal Neonatal Med 2010; 15:1.</a></li></ol></div><div id="topicVersionRevision">Topic 13515 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22409407" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Revisiting the histopathologic spectrum of congenital pulmonary developmental disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3448653" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The continuum of pulmonary developmental anomalies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Congenital Malformations and Developmental Anomalies of the Lung</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25394612" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Fetal bronchopulmonary malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12751868" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prenatal sonographic features of intralobar bronchopulmonary sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20283082" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Lower accessory pulmonary artery with intralobar sequestration of lung; a report of seven cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19194869" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Fetal retroperitoneal pulmonary sequestration with an atypical vascular pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26046453" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Fetal laser surgery prevents fetal death and avoids the need for neonatal sequestrectomy in cases with bronchopulmonary sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18392629" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Congenital cystic lung disease: contemporary antenatal and postnatal management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19453525" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Imaging in bronchopulmonary sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31451177" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Congenital lung lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20304322" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Current imaging of prenatally diagnosed congenital lung lesions</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22901907" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The diagnosis and management of intradiaphragmatic extralobar pulmonary sequestrations: a report of 4 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25667716" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Antenatal diagnosis of extralobar pulmonar sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24764345" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Imaging and differential diagnosis of suprarenal masses in the fetus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24022880" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Extralobar pulmonary sequestration with combined gastric and intradiaphragmatic locations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17558209" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Fetal magnetic resonance imaging as a complement to fetal ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23525748" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Congenital lung lesions: prenatal MRI and postnatal findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9323669" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sonographic detection of bilateral fetal chest masses: report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10405718" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Congenital chest lesions: diagnosis and characterization with prenatal MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19106364" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Perinatal imaging in bronchopulmonary sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18634115" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cystic lung lesions - prenatal diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5652625" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Congenital bronchopulmonary-foregut malformation. Pulmonary sequestration communicating with the gastrointestinal tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11877643" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24258515" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Retrospective study of prenatal diagnosed pulmonary sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29268259" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Systemic Venous Drainage Is Associated with an Unfavorable Prenatal Behavior in Fetal Bronchopulmonary Sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20228324" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Congenital chest malformations: a multimodality approach with emphasis on fetal MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30049725" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Diagnostic accuracy of imaging studies in congenital lung malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Prenatal imaging of bronchopulmonary malformations: Is there a role for late third trimester fetal MRI?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19643792" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Prenatal diagnosis of congenital lobar emphysema: case report and review of the literature</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19740261" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Congenital lung malformation: evaluation of prenatal and postnatal radiological findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26653945" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Pathology of asymptomatic, prenatally diagnosed cystic lung malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9790364" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Fetal lung lesions: management and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25659425" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Fetal MRI of Torsed Bronchopulmonary Sequestration with Tension Hydrothorax and Hydrops in a Twin Gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12695920" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The value of fast MR imaging as an adjunct to ultrasound in prenatal diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19911412" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Hyperechoic congenital lung lesions in a non-selected population: from prenatal detection till perinatal management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29229484" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prenatal growth characteristics and pre/postnatal management of bronchopulmonary sequestrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17208551" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Fetal intervention for mass lesions and hydrops improves outcome: a 15-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16032766" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Should determination of the karyotype be systematic for all malformations detected by obstetrical ultrasound?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7991511" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Karyotype abnormalities in fetuses diagnosed as abnormal on ultrasound before 20 weeks' gestational age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1837358" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Ultrasound diagnosis of fetal abnormalities and cytogenetic evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1355807" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Ultrasonographically detectable markers of fetal chromosomal abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8650127" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Distribution of abnormal karyotypes among malformed fetuses detected by ultrasound throughout gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28809041" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Complex malformations involving the fetal body wall - definition and classification issues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37565521" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Association of prenatal thoracic ultrasound abnormalities with copy number variants at a single Chinese tertiary center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32267001" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Nonimmune hydrops fetalis: Genetic analysis and clinical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26978067" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prenatal Diagnosis and Evaluation of Sonographic Predictors for Intervention and Adverse Outcome in Congenital Pulmonary Airway Malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12418767" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Fetal therapy: state of the art.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26135786" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Spontaneous regression of intralobar pulmonary sequestration during the pregnancy: report of two cases through relationships between mass and fetal biometry and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32501205" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Infant Mortality in the United States, 2017: Data From the Period Linked Birth/Infant Death File.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18634114" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : In utero therapy for fetal thoracic abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27705970" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Successful in utero Percutaneous Fetoscopic Release of a Wrapped Pleuro-Amniotic Shunt around the Fetal Arm: Case Report and Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26183219" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Unusual pleuroamniotic shunt complication managed using a two-port in-CO2 fetoscopic technique: technical and ethical considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19293587" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Giant pulmonary sequestration: the rare case requiring the EXIT procedure with resection and ECMO.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19681165" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Single-needle laser treatment with drainage of hydrothorax in fetal bronchopulmonary sequestration with hydrops.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17352451" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Successful ultrasound-guided laser treatment of fetal hydrops caused by pulmonary sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17715320" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Percutaneous intrauterine laser ablation of the abnormal vessel in pulmonary sequestration with hydrops at 29 weeks' gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24407869" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Bronchopulmonary sequestration with massive pleural effusion: pleuroamniotic shunting vs intrafetal vascular laser ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22990987" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Percutaneous laser ablation under ultrasound guidance for fetal hyperechogenic microcystic lung lesions with hydrops: a single center cohort and a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28898888" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Outcome of Bronchopulmonary Sequestration with Massive Pleural Effusion after Intrafetal Vascular Laser Ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37664529" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Successful Elective Thoracoscopic Resection of Complicate Extralobar Bronchopulmonary Sequestration after Intrafoetal Vascular Laser Ablation: The Paediatric Surgeon's Point of View.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36577394" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Successful Treatment of Bronchopulmonary Sequestration by Radiofrequency Ablation of Feeding Artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17444552" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Percutaneous ultrasound-guided sclerotherapy for complicated fetal intralobar bronchopulmonary sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30574430" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Bronchopulmonary Sequestration with Fetal Hydrops in a Monochorionic Twin Successfully Treated with Multiple Courses of Betamethasone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29553854" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Effect of maternal betamethasone on hydrops fetalis caused by extralobar pulmonary sequestration: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17950681" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Antenatal diagnosis and management of congenital cystic adenomatoid malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17001747" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : In-utero pulmonary drainage in the management of primary hydrothorax and congenital cystic lung lesion: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35065806" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Delivery planning for congenital lung malformations: A CVR based perinatal care algorithm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19540178" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Open fetal surgery for life-threatening fetal anomalies.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
